NEW DELHI: For thousands of Indians living with heart failure, the biggest strain is not just the disease, but the cost of surviving it. A nationwide study has found that seven out of 10 patients have no financial protection, forcing families to pay almost entirely from their own pockets.Published in the journal Global Heart, the study led by Dr Panniyammakal Jeemon of SCTIMST, Thiruvananthapuram, analysed 1,859 patients across 21 tertiary hospitals in India between September 2019 and December 2022.It shows that over 90% of treatment expenses are borne directly by patients, exposing a deep gap in financial protection for chronic illnesses.The numbers reflect a harsh reality. On average, a patient spends more than ₹1 lakh a year on treatment. At the same time, incomes are falling — nearly one in three patients and over a third of households reported a drop in earnings after diagnosis.Doctors say income often drops as patients stop working and families cut back to provide care. About 38% face catastrophic spending and nearly one in six borrow or sell assets, with many cutting basic expenses. The burden is highest on rural, low-income and uninsured patients.Insurance offers some relief — but not enough. Schemes such as Ayushman Bharat provide coverage for hospitalisation, but gaps remain. Most schemes do not fully cover outpatient care, medicines and long-term follow-up — which form a major part of treatment in chronic conditions like heart failure. As a result, patients continue to spend heavily from their own pockets.“Heart failure care in India shows a clear gap between acute treatment and long-term management, driven by affordability, accessibility and availability,” said Dr Mohit Gupta, cardiologist at GTB Hospital. “Costs often force patients to cut medicines, delay follow-ups or skip tests. The biggest burden is repeated hospitalisation, not drugs. We frequently tailor treatment to what patients can afford. Insurance largely cover hospitalisation, but heart failure is a chronic outpatient disease, and gaps in covering medicines and follow-up care leave patients vulnerable. Expanding access to affordable drugs and structured follow-up can improve outcomes and reduce costs.”Dr Ambuj Roy, Prof in cardiology, AIIMS said that insurance schemes still favour one-time procedures over sustained care, while heart diseases demand long-term therapy. Even though newer drugs have improved survival and quality of life, most patients pay out of pocket, making heart failure treatment a significant financial burden.”Experts warn financial strain leads to delayed care and skipped medicines, worsening outcomes. Despite improved access, financial protection lags, making coverage of outpatient care and medicines critical.About the AuthorAnuja JaiswalAnuja Jaiswal is a Senior Assistant Editor at The Times of India, with an impressive 18-year career in narrative journalism. She specializes in health and heritage reporting, expertly simplifying complex health information to make it engaging and understandable for readers. Her deep dives into heritage topics are well-researched, resulting in captivating narratives that resonate with her audience. Over the years, she has worked in Chandigarh, Chhattisgarh and West UP, gaining diverse on-ground experience that shapes her storytelling.Read MoreEnd of ArticleFollow Us On Social MediaVideosArvind Kejriwal Shocks Court With Refusal To Appear In Excise Case“Hope Of Justice Shattered”: Kejriwal Skips Court, Sends Letter To Justice Swarana KantaAAP Workers Detained Outside Raghav Chadha’s House During Mumbai Protest“Fix Delhi And Pahalgam First” West Bengal CM Mamata Banerjee Launches Fierce Attack On BJP“TMC’s Time Is Over” Amit Shah Tears Into TMC Over Infiltrators During Bengal RallyPassport Row Escalates: Pawan Khera Approaches Supreme Court After Gauhati HC Rejects Bail PleaBJP MP Sudhanshu Trivedi Attacks TMC, Raises RG Kar Case And Law And Order ConcernsPM Narendra Modi To Inaugurate 594 Km Ganga Expressway In Uttar Pradesh On April 29“India Expands Global Trade Reach” Union Minister Piyush Goyal On NZ FTAMarathi Mandatory In Maharashtra From May 1 |CM Fadnavis Pushes Language Rule For Auto, Taxi Drivers123PhotostoriesWhat is your inner calling based on your birth dateThese 5 Zodiac Signs Will Find Their Person This Year5 cutest cat breeds in 2026 that are taking over the internet right now5 simple moves that stop blood sugar spikes after every meal8 healthy infused waters that are a must have in summer for healthy digestion6 common flight mistakes by that may cost travellers their health7 best British trees for a front garden that looks good all year (and how to maintain them through every season)Copy-paste genetics? These 5 celebrity kids look exactly like their parents5 Indian summer fruits you can grow in the backyard7 radiant baby girl names that symbolise sunshine123Hot PicksTamil Nadu ElectionWest Bengal voter turnoutAssembly Election 2026Mamata BanerjeeTamil Nadu voter turnoutAmit ShahPM ModiTop TrendingRussini Mike Photo ControversyTamil Nadu electionNFL Trade RumorsPetrol Diesel PriceAIIMS B.Sc. coursesJac Class 12 ResultPatrick MahomesBengal PollsNirmala SitharamanIPL Orange Cap
NEW DELHI: For thousands of Indians living with heart failure, the biggest strain is not just the disease, but the cost of surviving it. A nationwide study has found that seven out of 10 patients have no financial protection, forcing families to pay almost entirely from their own pockets.Published in the journal Global Heart, the study led by Dr Panniyammakal Jeemon of SCTIMST, Thiruvananthapuram, analysed 1,859 patients across 21 tertiary hospitals in India between September 2019 and December 2022.It shows that over 90% of treatment expenses are borne directly by patients, exposing a deep gap in financial protection for chronic illnesses.The numbers reflect a harsh reality. On average, a patient spends more than ₹1 lakh a year on treatment. At the same time, incomes are falling — nearly one in three patients and over a third of households reported a drop in earnings after diagnosis.Doctors say income often drops as patients stop working and families cut back to provide care. About 38% face catastrophic spending and nearly one in six borrow or sell assets, with many cutting basic expenses. The burden is highest on rural, low-income and uninsured patients.Insurance offers some relief — but not enough. Schemes such as Ayushman Bharat provide coverage for hospitalisation, but gaps remain. Most schemes do not fully cover outpatient care, medicines and long-term follow-up — which form a major part of treatment in chronic conditions like heart failure. As a result, patients continue to spend heavily from their own pockets.“Heart failure care in India shows a clear gap between acute treatment and long-term management, driven by affordability, accessibility and availability,” said Dr Mohit Gupta, cardiologist at GTB Hospital. “Costs often force patients to cut medicines, delay follow-ups or skip tests. The biggest burden is repeated hospitalisation, not drugs. We frequently tailor treatment to what patients can afford. Insurance largely cover hospitalisation, but heart failure is a chronic outpatient disease, and gaps in covering medicines and follow-up care leave patients vulnerable. Expanding access to affordable drugs and structured follow-up can improve outcomes and reduce costs.”Dr Ambuj Roy, Prof in cardiology, AIIMS said that insurance schemes still favour one-time procedures over sustained care, while heart diseases demand long-term therapy. Even though newer drugs have improved survival and quality of life, most patients pay out of pocket, making heart failure treatment a significant financial burden.”Experts warn financial strain leads to delayed care and skipped medicines, worsening outcomes. Despite improved access, financial protection lags, making coverage of outpatient care and medicines critical.
